PharmaMar’s novel ADC demonstrates anticancer activity in HER2-expressing
This news release is available in Spanish. PharmaMar (MSE:PHM), a world-leading biopharmaceutical company in the discovery and development of innovative marine-derived anticancer drugs, announced to..












